Results 131 to 140 of about 10,858 (213)

Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing [PDF]

, 2016
Chaponda, Mas, Khoo, Saye, Lewis, Joseph M, Railton, Eimear, Riordan, Andrew   +4 more
core   +1 more source

Evaluation of the Efficacy of Tenofovir Alafenamide in Patients with Low-Level Viremia Under Chronic Hepatitis B Treatment. [PDF]

Viruses
Tahmaz A, Yıldız Dikmen M, Yıldırım F, Öztürk Kaygusuz T, Karabay O, Çelen MK, Alkan S, Damar Çakırca T, Akgül F, Akhan S, Gürbüz E, Özer Balin Ş, Çelik M, Çabalak M.   +13 more
europepmc   +1 more source

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort. [PDF]

HIV AIDS (Auckl)
Inciarte A, Miralles C, Silva-Klug A, Revollo B, García Deltoro M, Portilla J, Antela A, Castaño Carracedo MÁ, De Álvaro C, Ramroth J, González-Cordón A, Mallolas J.   +11 more
europepmc   +1 more source

A retrospective comparative study of tenofovir alafenamide and tenofovir disoproxil fumarate in chronic hepatitis B patients: Renal and bone safety versus antiviral efficacy. [PDF]

Medicine (Baltimore)
Wang L, Pi G, Lu D, Wang Y, Sun W.
europepmc   +1 more source

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. [PDF]

PLoS One
Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IL, Sorni P, Cabello-Clotet N, Montero M, Font CR, Terron A, Galindo MJ, Martinez O, Ryan P, Omar-Mohamed M, Albendín-Iglesias H, Javier R, Romero A, Vallecillos CG, Calleja MÁ, Hidalgo-Tenorio C.   +19 more
europepmc   +1 more source

Nationwide analysis of renal outcomes in chronic hepatitis B patients treated with Tenofovir Alafenamide vs. Entecavir. [PDF]

Sci Rep
Kim H, Kim JY, Yoo HJ, Kim LY, Yoo JJ, Kim SG, Kim YS.   +6 more
europepmc   +1 more source

Virologic, immunologic, and metabolic outcomes and mortality in people with HIV on bictegravir/emtricitabine/tenofovir alafenamide fumarate versus dolutegravir-based antiretroviral therapies: a retrospective multicenter cohort study in China. [PDF]

Lancet Reg Health West Pac
Wu X, Ma P, Ruan L, Chen Y, Wang R, Song Y, Cai Y, Chen F, Zhang L, Fitzpatrick T, Li B, Wu G, Meng X, Fan S, Qiao Y, Gao Y, Hong Z, Zhang T, Zou M, Wang L, Fu Y, Su B, Zou J, Wang H, Zou H.   +24 more
europepmc   +1 more source

Patient Characteristics and Reasons for Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Retrospective Cohort From a Large Urban HIV Clinic. [PDF]

Cureus
Gao H, Manchukonda B, Simoes P, Hamlyn E, Barber TJ, Hunter A, Hart J, Johnson M, Kinloch-de Loes S.   +8 more
europepmc   +1 more source

Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial. [PDF]

Hepatol Commun
Tabataba Vakili S, Hirode G, Zahoor A, Saunthar A, Feld JB, Hansen BE, Syeda A, Janssen HLA, Kukreti V, Kuruvilla J, Prica A, Cheung M, Buckstein R, Hicks L, Coffin CS, Street LE, Disperati P, Chan KK, Crump M, Feld JJ.   +19 more
europepmc   +1 more source

Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies. [PDF]

Infect Dis Ther
Antinori A, Yokomaku Y, Elinav H, Pullukçu H, de Wet J, Antela A, Lu PL, Sabranski M, Kim YS, Bonnet F, den Hollander J, Jackson A, Choy CY, Cai W, Zhang F, Thorpe D, Marongiu A, Harrison R, Jarrett J, Boffito M.   +19 more
europepmc   +1 more source